Polybiomics
PrivateLast Round
Accelerator
Sep 19, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Polybiomics is a biotechnology company that develops a live-cell analysis platform for drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Polybiomics Comparables
Compare Polybiomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Holobiome | 83% | |
| Pragma Bio | 81% | |
| Kanvas Biosciences | 79% |
Polybiomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 19, 2025 | ||||
| Accelerator | May 29, 2024 | ||||
| Accelerator | May 14, 2024 |
Polybiomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Accelerator |
| WTIA Startup Program | Accelerator |
| BioTools Innovator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 19, 2025
Received funding from Plug and Play Tech Center.
- May 29, 2024
BioTools Innovator participated in the round.
Polybiomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Polybiomics's valuation, stock price, and market status.
Is Polybiomics a public or private company?
Polybiomics is a private company.
What is the current stock price of Polybiomics?
Polybiomics is a private company with no public stock price. Caplight tracks Polybiomics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Polybiomics worth (valuation)?
Valuation information for Polybiomics is not publicly available.
Can I buy Polybiomics stock?
Polybiomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Polybiomics's last funding round?
Polybiomics's most recent funding round was Accelerator on September 19, 2025.
Who are the main investors in Polybiomics?
Key investors in Polybiomics include Plug and Play Tech Center, WTIA Startup Program, BioTools Innovator.
Will Polybiomics IPO soon?
No public IPO plans have been announced for Polybiomics.
How can I track Polybiomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Polybiomics's secondary market activity and sign up for updates.